Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

This study will use brain Positron Emission Tomography/ Magnetic Resonance Imaging (PET/MRI) and an investigational radioactive drug called \[Zr-89\]oxine to track the location of white blood cells (also called leukocytes) in the body. PET/MRI will be used to visualize labeled white blood cells and determine if they enter the central nervous system in conditions associated with brain inflammation (also called neuroinflammation). By better understanding the role of neuroinflammation in fibromyalgia, chronic fatigue syndrome, and multiple sclerosis, the investigator hopes to be able to better diagnose and treat patients in the future.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• 18 to 65 years of age 2.Healthy volunteer OR

• Clinical diagnosis of Multiple Sclerosis (MS) OR

• Meets 2016 American College of Rheumatology (ACR) case definition criteria for fibromyalgia OR

• Meets 1994 Fukuda case definition criteria for Chronic Fatigue Syndrome

Locations
United States
Alabama
UAB
RECRUITING
Birmingham
Contact Information
Primary
Jonathan McConathy, MD, PhD
jmcconathy@uabmc.edu
205-996-7115
Backup
Evan Hudson, BS
evanhudson@uabmc.edu
205-934-6499
Time Frame
Start Date: 2021-10-05
Estimated Completion Date: 2028-10
Participants
Target number of participants: 120
Treatments
Experimental: Fibromyalgia
Experimental: Chronic Fatigue Syndrome
Experimental: Multiple Sclerosis
Experimental: Healthy Controls
Sponsors
Leads: University of Alabama at Birmingham

This content was sourced from clinicaltrials.gov

Similar Clinical Trials